Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2017-03-13 2017-03-13
Drug Identification Number 02167603 02167603
Brand name LIDODAN JELLY 2%(SINGLE USE SYRINGE) LIDODAN JELLY 2%(SINGLE USE SYRINGE)
Common or Proper name Lidocaine Hydrochloride Jelly, USP Lidocaine Hydrochloride Jelly, USP
Company Name ODAN LABORATORIES LTD ODAN LABORATORIES LTD
Ingredients LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE
Strength(s) 2% 2%
Dosage form(s) JELLY JELLY
Route of administration TOPICAL TOPICAL
Packaging size 10 mL 10 mL
ATC code D04AB D04AB
ATC description ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC. ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-06-21 2016-06-21
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments